Cargando…

Molecular mechanisms and mode of tamoxifen resistance in breast cancer

Breast cancer is one of the most common cancers in women around the globe Tamoxifen is used for the last 40 years as an endocrine therapy for breast cancer. This resulted in the reduction of mortality rate by 30% and it still remains one of the most effective therapies against breast cancer. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Shazia, Rasool, Mahmood, Chaoudhry, Hani, N Pushparaj, Peter, Jha, Prakash, Hafiz, Abdul, Mahfooz, Maryam, Abdus Sami, Ghufrana, Azhar Kamal, Mohammad, Bashir, Sania, Ali, Ashraf, Sarwar Jamal, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5267957/
https://www.ncbi.nlm.nih.gov/pubmed/28149048
http://dx.doi.org/10.6026/97320630012135
_version_ 1782500726840229888
author Ali, Shazia
Rasool, Mahmood
Chaoudhry, Hani
N Pushparaj, Peter
Jha, Prakash
Hafiz, Abdul
Mahfooz, Maryam
Abdus Sami, Ghufrana
Azhar Kamal, Mohammad
Bashir, Sania
Ali, Ashraf
Sarwar Jamal, Mohammad
author_facet Ali, Shazia
Rasool, Mahmood
Chaoudhry, Hani
N Pushparaj, Peter
Jha, Prakash
Hafiz, Abdul
Mahfooz, Maryam
Abdus Sami, Ghufrana
Azhar Kamal, Mohammad
Bashir, Sania
Ali, Ashraf
Sarwar Jamal, Mohammad
author_sort Ali, Shazia
collection PubMed
description Breast cancer is one of the most common cancers in women around the globe Tamoxifen is used for the last 40 years as an endocrine therapy for breast cancer. This resulted in the reduction of mortality rate by 30% and it still remains one of the most effective therapies against breast cancer. However, resistance against tamoxifen is still one of the major hurdles in the effective management of breast cancer. Intense research has been conducted in the past decade to further explore its resistance mechanism, but still a lot of research will be needed to effectively alleviate this problem. Several biochemical factors and molecular pathways, such as the modulation of ER signaling, upregulation of growth factors had been observed as key factors for tamoxifen resistance (TR). After, initial therapy of five to ten years, breast cancer patients develops resistance towards this drug. The resistance leads to the development of other cancers like uterine cancer. Here, we briefly explore all the molecular events related to tamoxifen resistance and focus on its mechanism of action as well as other pharmacological approaches to better its beneficial effects in the treatment of breast carcinoma.
format Online
Article
Text
id pubmed-5267957
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Biomedical Informatics
record_format MEDLINE/PubMed
spelling pubmed-52679572017-02-01 Molecular mechanisms and mode of tamoxifen resistance in breast cancer Ali, Shazia Rasool, Mahmood Chaoudhry, Hani N Pushparaj, Peter Jha, Prakash Hafiz, Abdul Mahfooz, Maryam Abdus Sami, Ghufrana Azhar Kamal, Mohammad Bashir, Sania Ali, Ashraf Sarwar Jamal, Mohammad Bioinformation Review Breast cancer is one of the most common cancers in women around the globe Tamoxifen is used for the last 40 years as an endocrine therapy for breast cancer. This resulted in the reduction of mortality rate by 30% and it still remains one of the most effective therapies against breast cancer. However, resistance against tamoxifen is still one of the major hurdles in the effective management of breast cancer. Intense research has been conducted in the past decade to further explore its resistance mechanism, but still a lot of research will be needed to effectively alleviate this problem. Several biochemical factors and molecular pathways, such as the modulation of ER signaling, upregulation of growth factors had been observed as key factors for tamoxifen resistance (TR). After, initial therapy of five to ten years, breast cancer patients develops resistance towards this drug. The resistance leads to the development of other cancers like uterine cancer. Here, we briefly explore all the molecular events related to tamoxifen resistance and focus on its mechanism of action as well as other pharmacological approaches to better its beneficial effects in the treatment of breast carcinoma. Biomedical Informatics 2016-06-15 /pmc/articles/PMC5267957/ /pubmed/28149048 http://dx.doi.org/10.6026/97320630012135 Text en © 2016 Biomedical Informatics http://creativecommons.org/licenses/by/3.0/ This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
spellingShingle Review
Ali, Shazia
Rasool, Mahmood
Chaoudhry, Hani
N Pushparaj, Peter
Jha, Prakash
Hafiz, Abdul
Mahfooz, Maryam
Abdus Sami, Ghufrana
Azhar Kamal, Mohammad
Bashir, Sania
Ali, Ashraf
Sarwar Jamal, Mohammad
Molecular mechanisms and mode of tamoxifen resistance in breast cancer
title Molecular mechanisms and mode of tamoxifen resistance in breast cancer
title_full Molecular mechanisms and mode of tamoxifen resistance in breast cancer
title_fullStr Molecular mechanisms and mode of tamoxifen resistance in breast cancer
title_full_unstemmed Molecular mechanisms and mode of tamoxifen resistance in breast cancer
title_short Molecular mechanisms and mode of tamoxifen resistance in breast cancer
title_sort molecular mechanisms and mode of tamoxifen resistance in breast cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5267957/
https://www.ncbi.nlm.nih.gov/pubmed/28149048
http://dx.doi.org/10.6026/97320630012135
work_keys_str_mv AT alishazia molecularmechanismsandmodeoftamoxifenresistanceinbreastcancer
AT rasoolmahmood molecularmechanismsandmodeoftamoxifenresistanceinbreastcancer
AT chaoudhryhani molecularmechanismsandmodeoftamoxifenresistanceinbreastcancer
AT npushparajpeter molecularmechanismsandmodeoftamoxifenresistanceinbreastcancer
AT jhaprakash molecularmechanismsandmodeoftamoxifenresistanceinbreastcancer
AT hafizabdul molecularmechanismsandmodeoftamoxifenresistanceinbreastcancer
AT mahfoozmaryam molecularmechanismsandmodeoftamoxifenresistanceinbreastcancer
AT abdussamighufrana molecularmechanismsandmodeoftamoxifenresistanceinbreastcancer
AT azharkamalmohammad molecularmechanismsandmodeoftamoxifenresistanceinbreastcancer
AT bashirsania molecularmechanismsandmodeoftamoxifenresistanceinbreastcancer
AT aliashraf molecularmechanismsandmodeoftamoxifenresistanceinbreastcancer
AT sarwarjamalmohammad molecularmechanismsandmodeoftamoxifenresistanceinbreastcancer